Last update 24 Jan 2026

Compound 39f(Shanghai University of Traditional Chinese Medicine)

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
HDACs
Action
inhibitors
Mechanism
HDAC inhibitors(Histone deacetylase inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Neoplasms
Inactive Indication-
Originator Organization
Shanghai University of Traditional Chinese MedicineShanghai University of Traditional Chinese MedicineDalianhualijingang Pharmaceutical Co. Ltd.Dalianhualijingang Pharmaceutical Co. Ltd.
Active Organization
Dalianhualijingang Pharmaceutical Co. Ltd.Dalianhualijingang Pharmaceutical Co. Ltd.Shanghai University of Traditional Chinese MedicineShanghai University of Traditional Chinese MedicineHangzhou Normal UniversityHangzhou Normal University
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Structure/Sequence

Molecular FormulaC30H47N5O3
InChIKeyKGRXBHVHPSCGPJ-HRHHFINDSA-N
CAS Registry2821923-86-6

Related

100 Clinical Results associated with Compound 39f(Shanghai University of Traditional Chinese Medicine)
Login to view more data
100 Translational Medicine associated with Compound 39f(Shanghai University of Traditional Chinese Medicine)
Login to view more data
100 Patents (Medical) associated with Compound 39f(Shanghai University of Traditional Chinese Medicine)
Login to view more data
100 Deals associated with Compound 39f(Shanghai University of Traditional Chinese Medicine)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPreclinical
China
Dalianhualijingang Pharmaceutical Co. Ltd.Dalianhualijingang Pharmaceutical Co. Ltd.
04 Apr 2023
NeoplasmsPreclinical
China
Shanghai University of Traditional Chinese MedicineShanghai University of Traditional Chinese Medicine
04 Apr 2023
NeoplasmsPreclinical
China
Hangzhou Normal UniversityHangzhou Normal University
04 Apr 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free